1 not yet recruiting, 1 unknown, 1 withdrawn. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
| Phase 3 | 1 | Unknown 1 |
Follow CLAG: new trials by email Literature Review of CLAG trials Research Report on CLAG
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multicenter Prospective Cohort Study Study of CLAG Regimen in Acute Myeloid Leukemia Patients With First-induction Failure CLAG - AML | Not yet recruiting | Nanfang Hospital, Southern Medical University | 137 | 2023-07-02 | 2023-07-05 | |
| Role of the Therapy Tailored to Risk Factors in Treating Adult Patients (≤60) With Acute Myeloid Leukemia DAC, CLAG, Consolidation, I HAM cycle - Acute Myeloid Leukemia | Phase 3 | Unknown | dr hab. n. med. Agnieszka Wierzbowska | 400 | 2014-02-01 | 2014-02-27 |
| A Study Evaluating the Effects of CLAG With Gleevec in Refractory or Relapsed Acute Myeloid Leukemia Imatinib Mesylate, CLAG - Chronic Myeloid Leukemia, Blast Crisis, Acute Myeloid Leukemia | Phase 2 | Withdrawn | University of Cincinnati | 20 | 2007-11-01 | 2008-10-31 |
Leukemia, Myeloid, Acute (3) · Blast Crisis (1) · Hematologic Diseases (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)
Nanfang Hospital, Southern Medical University (1) · University of Cincinnati (1) · dr hab. n. med. Agnieszka Wierzbowska (1)
China (1) · Poland (1) · United States (1)
Rami S Komrokji, MD (1) · Xuejie Jiang, Doctor (1)